Noticing education campaigns or public health messages about vaping among youth in the United States, Canada and England from 2018 to 2022.


Journal

Health education research
ISSN: 1465-3648
Titre abrégé: Health Educ Res
Pays: England
ID NLM: 8608459

Informations de publication

Date de publication:
02 Jan 2024
Historique:
received: 14 06 2023
revised: 29 11 2023
accepted: 08 12 2023
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 2 1 2024
Statut: aheadofprint

Résumé

Public health campaigns have the potential to correct vaping misperceptions. However, campaigns highlighting vaping harms to youth may increase misperceptions that vaping is equally/more harmful than smoking. Vaping campaigns have been implemented in the United States and Canada since 2018 and in England since 2017 but with differing focus: youth vaping prevention (United States/Canada) and smoking cessation (England). We therefore examined country differences and trends in noticing vaping campaigns among youth and, using 2022 data only, perceived valence of campaigns and associations with harm perceptions. Seven repeated cross-sectional surveys of 16-19 year-olds in United States, Canada and England (2018-2022, n = 92 339). Over half of youth reported noticing vaping campaigns, and noticing increased from August 2018 to February 2020 (United States: 55.2% to 74.6%, AOR = 1.21, 95% CI = 1.18-1.24; Canada: 52.6% to 64.5%, AOR = 1.13, 1.11-1.16; England: 48.0% to 53.0%, AOR = 1.05, 1.02-1.08) before decreasing (Canada) or plateauing (England/United States) to August 2022. Increases were most pronounced in the United States, then Canada. Noticing was most common on websites/social media, school and television/radio. In 2022 only, most campaigns were perceived to negatively portray vaping and this was associated with accurately perceiving vaping as less harmful than smoking among youth who exclusively vaped (AOR = 1.46, 1.09-1.97). Consistent with implementation of youth vaping prevention campaigns in the United States and Canada, most youth reported noticing vaping campaigns/messages, and most were perceived to negatively portray vaping.

Identifiants

pubmed: 38165724
pii: 7505052
doi: 10.1093/her/cyad044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : 1P01CA200512 R37CA222002
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Katherine East (K)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.
School of Public Health Sciences, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.

Eve Taylor (E)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.

Erikas Simonavičius (E)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.

Matilda Nottage (M)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.

Jessica L Reid (JL)

School of Public Health Sciences, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.

Robin Burkhalter (R)

School of Public Health Sciences, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.

Leonie Brose (L)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.

Olivia A Wackowski (OA)

School of Public Health, Rutgers, The State University of New Jersey, 683 Hoes Lane West, Piscataway, NJ 08854, USA.

Alex C Liber (AC)

Cancer Prevention and Control, Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC 20007, USA.

Ann McNeill (A)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Addictions Sciences Building, 4 Windsor Walk, London SE5 8BB, UK.

David Hammond (D)

School of Public Health Sciences, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.

Classifications MeSH